Perfil
Steven J.
Swanson worked as the Head of Clinical Immunology at Amgen, Inc. He then worked as the Senior Vice President of Research at ImmunoCellular Therapeutics Ltd.
from 2015 to 2018.
Swanson received his undergraduate degree from North Central College and his doctorate from the University of Iowa.
Antiguos cargos conocidos de Steven J. Swanson.
| Empresas | Cargo | Fin |
|---|---|---|
| EOM PHARMACEUTICALS HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 15/10/2018 |
| AMGEN INC. | Corporate Officer/Principal | - |
Formación de Steven J. Swanson.
| North Central College | Undergraduate Degree |
| University of Iowa | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| AMGEN INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
ImmunoCellular Therapeutics Ltd.
 ImmunoCellular Therapeutics Ltd. BiotechnologyHealth Technology ImmunoCellular Therapeutics, Ltd. is a clinical-stage pharmaceutical company, focused on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis. The company also develops EOM 147, an investigational, broad-spectrum aminosterol with an intracellular mechanism for the treatment of chronic and debilitating retinal diseases. The company was founded on March 20, 1987 and is headquartered in Montvale, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Steven J. Swanson
